Leucadia and FXCM Complete Long-Term Partnership Agreement
Sep 01, 2016 11:30 am UTC| Business
NEW YORK, Sept. 01, 2016 -- Leucadia National Corporation (NYSE:LUK) (“Leucadia”) and FXCM Inc.(NYSE:FXCM) (“FXCM”) today announced that they have completed the process of deepening their partnership, with Leucadia now...
Tandy Leather Factory, Inc. Reports August 2016 Sales Equal to August 2015 Sales
Sep 01, 2016 11:30 am UTC| Business
FORT WORTH, Texas, Sept. 01, 2016 -- Tandy Leather Factory, Inc. (NASDAQ:TLF) reported today that sales for the month of August were $6.4 million, equal to August 2015 sales of $6.4 million. Year to date sales were...
Amicus Therapeutics to Present at Robert W. Baird & Co. 2016 Healthcare Conference
Sep 01, 2016 11:30 am UTC| Business
CRANBURY, N.J., Sept. 01, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, will...
Otonomy to Present at Baird Global Healthcare Conference
Sep 01, 2016 11:30 am UTC| Business
SAN DIEGO, Sept. 01, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced...
Cempra to Present at Three Upcoming Investor Conferences
Sep 01, 2016 11:30 am UTC| Business
CHAPEL HILL, N.C., Sept. 01, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious...
Pacira Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
Sep 01, 2016 11:30 am UTC| Business
PARSIPPANY, N.J., Sept. 01, 2016 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that Dave Stack, Chief Executive Officer and Chairman of Pacira Pharmaceuticals, is scheduled to present at the Morgan...
Repligen to Present at Baird Global Healthcare Conference 2016
Sep 01, 2016 11:30 am UTC| Business
WALTHAM, Mass., Sept. 01, 2016 -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs, today announced that Tony J. Hunt,...